Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-263618
Filing Date
2025-11-04
Accepted
2025-11-04 08:00:50
Documents
61
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-20250930.htm   iXBRL 10-Q 2368959
2 EX-10.1 hrtx-ex10_1.htm EX-10.1 242927
3 EX-10.7 hrtx-ex10_7.htm EX-10.7 1039506
4 EX-10.8 hrtx-ex10_8.htm EX-10.8 23712
5 EX-31.1 hrtx-ex31_1.htm EX-31.1 17480
6 EX-31.2 hrtx-ex31_2.htm EX-31.2 17226
7 EX-32.1 hrtx-ex32_1.htm EX-32.1 19365
  Complete submission text file 0001193125-25-263618.txt   10419869

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20250930.xsd EX-101.SCH 996612
64 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20250930_htm.xml XML 1716698
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 251446510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)